The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
about
Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teethOncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceOsteoimmunology: interactions of the bone and immune systemCiliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodelingParathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.Contribution of interleukin-11 and prostaglandin(s) in lipopolysaccharide-induced bone resorption in vivo.IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells.Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment.Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activityActivation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancersGlycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.Three-dimensional dynamic bone histomorphometry.PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.Interleukin 6 plays a key role in the development of antigen-induced arthritis.Rheumatic diseases: the effects of inflammation on bone.Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formationMechanisms involved in skeletal anabolic therapies.An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3Isolation and characterization of the human gp130 promoter. Regulation by STATS.Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis.Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unitMore than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer.Talking among ourselves: paracrine control of bone formation within the osteoblast lineage.IL-11 signaling as a therapeutic target for cancer.Effects of interleukin-11 on the expression of human bone sialoprotein gene.The mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers.Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines.STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroiA Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitroBone corticalization requires local SOCS3 activity and is promoted by androgen action via interleukin-6.A novel osteoblast-derived C-type lectin that inhibits osteoclast formation.Stimulation of IL-6 cytokines in fibroblasts by toll-like receptors 2.Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation.IL-6 induces osteoblastic differentiation of periodontal ligament cells.Osteogenic effect of interleukin-11 and synergism with ascorbic acid in human periodontal ligament cells.IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.
P2860
Q24312711-129976C5-20D2-452D-8352-B22D35A9D7F6Q24642117-7A1F8893-52CD-4B59-A582-E7F43F2DE770Q24655113-77010C3E-0B5D-4EE6-9B9C-241B4B09DE3FQ28273257-3FD231D4-C3D8-47DB-B183-C2DC3F2390BAQ33901231-C95BE2A6-4664-4BB5-813E-B5EF116EACF9Q34126507-99F19A2E-8691-4AF9-BA7B-7E8A60E8C542Q34545945-50ED19EF-48AD-4B63-8CEB-236C74288116Q34575607-22671C97-3D73-4B37-8BCF-84AF1AF180FFQ34675956-DD6403D2-00B0-418C-8590-C6EBF7C451DBQ35071128-A43032DB-D91C-4C53-8A76-5D7211E72F73Q35632149-7F7F9F8B-ED66-4DA2-9CDD-8B7AE75F1D25Q35784404-B7583F2D-7D8F-436A-B1D4-0AF39B17FB20Q36105975-112D270A-48ED-4575-9721-5D343A5F6A97Q36172826-A99DB63E-B78C-4163-A30C-1D791AED909AQ36324975-AD597096-4DD0-46CC-8C07-4D8A581102E3Q36377004-C7F021AC-0314-418E-B511-3930672B9711Q36532582-BDCFE2DF-5BA1-4BC8-B8ED-854A4B37F3C7Q36629317-947B420D-8BF4-4BBE-B9BD-5AA2F9B967C5Q36863399-6989FAD3-B92D-4050-BD6E-8BC07AFCF8AAQ37373492-A5FFAA69-1D1A-4EA9-9449-64A9C4A8818AQ37398115-75AA25F2-3504-4BFE-BDAE-2562463AFF77Q37506724-CA89E341-952E-44C8-8A5B-F27611363261Q37770826-E9D6690A-6CAE-4790-B0BB-8B487098FC2EQ38108518-2B168FC8-AA9D-41C5-8571-E13966BDD4E9Q38445355-93CCC2C7-7952-41D0-8099-63715C28F2B7Q39014991-CA5C1F31-F531-4627-BD4C-3E56C680052EQ39564377-AA48459A-0C21-40F1-91D1-49148C74E494Q40699804-638A8D4E-2CD9-41E9-B18C-483ECB4D1719Q40853809-CEA49D1B-0198-4A0D-B08D-160330BF7B9EQ40945774-1F321951-B46B-4FF4-8183-63C331C52B33Q41017658-B37F04AD-F799-4D8E-9961-696BC48FFB3DQ42266513-350804DC-0AB1-4147-A2F2-CE844666999FQ43560074-2C2A64C1-9F6D-4DCD-8125-D595436F8B33Q44025416-1113CE27-4B64-4812-9E88-A1AA80F4351FQ44774590-B6215EE5-E869-4505-B7DA-7A135A3F649AQ46352481-A6F8A1A4-EE70-4F4E-B920-35D1A4FA2154Q46935431-526BD37B-1F32-4020-9E04-3ED58C67B181Q53670887-AF83842B-772F-42C8-98B0-908A8232A4B9
P2860
The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
The role of gp130-mediated sig ...... eptor in bone marrow cultures.
@ast
The role of gp130-mediated sig ...... eptor in bone marrow cultures.
@en
type
label
The role of gp130-mediated sig ...... eptor in bone marrow cultures.
@ast
The role of gp130-mediated sig ...... eptor in bone marrow cultures.
@en
prefLabel
The role of gp130-mediated sig ...... eptor in bone marrow cultures.
@ast
The role of gp130-mediated sig ...... eptor in bone marrow cultures.
@en
P2093
P2860
P356
P1476
The role of gp130-mediated sig ...... ceptor in bone marrow cultures
@en
P2093
T J Martin
P2860
P304
P356
10.1084/JEM.183.6.2581
P407
P577
1996-06-01T00:00:00Z